53

Lotus Eye Hospital and Institute LtdBOM 532998 Stock Report

Last reporting period 30 Sep, 2023

Updated 13 Nov, 2024

Last price

Market cap $B

0.011

Micro

Exchange

XBOM - Bombay Stock Exchange

532998.BO Stock Analysis

53

Uncovered

Lotus Eye Hospital and Institute Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.011

Dividend yield

0.58 %

Shares outstanding

20.796 B

Lotus Eye Hospital & Institute Ltd. engages in the provision of eye care and related services. The company is headquartered in Coimbatore, Tamil Nadu. The company went IPO on 2008-07-11. The firm operates primarily in the field of ophthalmology (Eye) and its related operations. The company resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The firm provides treatments through ReLEx SMILE, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The firm operates approximately seven centers at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin, and Mulanthurthy.

View Section: Eyestock Rating